Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Edita Sarukhanyan
Rational Drug Design of Axl Tyrosine Kinase Type I Inhibitors as Promising Candidates Against Cancer
Frontiers in Chemistry
Chemistry
Related publications
AXL Receptor Tyrosine Kinase (AXL; UFO)
Science-Business eXchange
Tyrosine Kinase Inhibitors in Lung Cancer
Hematology/Oncology Clinics of North America
Oncology
Hematology
Inflammasome Inhibitors: Promising Therapeutic Approaches Against Cancer
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Computational Design of Druglike Allosteric Inhibitors of AXL and MET Receptor Tyrosine Kinases
Biophysical Journal
Biophysics
Tyrosine Kinase Inhibitors in Advanced Thyroid Cancer
Journal of the Siena Academy of Sciences
3d-Qsar Analysis of Pyrimidine Derivatives as AXL Kinase Inhibitors as Anticancer Agents
Journal of Applied Pharmaceutical Science
Medicine
Toxicology
Pharmaceutics
Pharmacology
Protein Tyrosine Kinase Panel as a Tool for Anticancer Drug Design
Acta Naturae
Biochemistry
Biotechnology
Molecular Medicine
Molecular Biology
Small Molecule Tyrosine Kinase Inhibitors in Pancreatic Cancer
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Receptor Tyrosine Kinase Axl Modulates the Osteogenic Differentiation of Pericytes
Circulation Research
Cardiovascular Medicine
Physiology
Cardiology